Fairview Capital Investment Management LLC cut its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 10.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 41,701 shares of the medical technology company's stock after selling 5,100 shares during the quarter. Fairview Capital Investment Management LLC owned about 0.09% of Teleflex worth $7,422,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the business. Headlands Technologies LLC acquired a new position in Teleflex in the 4th quarter valued at $29,000. Avior Wealth Management LLC grew its holdings in Teleflex by 81.2% in the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock valued at $50,000 after buying an additional 125 shares in the last quarter. IFP Advisors Inc grew its holdings in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after buying an additional 217 shares in the last quarter. Exchange Traded Concepts LLC grew its holdings in Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after buying an additional 94 shares in the last quarter. Finally, R Squared Ltd acquired a new position in Teleflex in the 4th quarter valued at $64,000. 95.62% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on TFX shares. Royal Bank of Canada reduced their target price on Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a report on Friday, May 2nd. Wells Fargo & Company reduced their target price on Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, May 2nd. Citizens Jmp lowered Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. Morgan Stanley reduced their target price on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a report on Monday, May 5th. Finally, Truist Financial reduced their target price on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a report on Monday, May 5th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $164.63.
Read Our Latest Research Report on TFX
Teleflex Stock Performance
Shares of NYSE:TFX traded down $1.08 during midday trading on Friday, reaching $125.10. 596,359 shares of the company traded hands, compared to its average volume of 641,215. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12 month low of $120.06 and a 12 month high of $249.91. The firm has a market capitalization of $5.53 billion, a price-to-earnings ratio of 24.87, a price-to-earnings-growth ratio of 1.73 and a beta of 1.17. The firm's fifty day moving average price is $133.86 and its two-hundred day moving average price is $165.91.
Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. During the same period in the prior year, the company earned $3.21 EPS. The company's quarterly revenue was down 5.0% compared to the same quarter last year. On average, equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.
Teleflex Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.09%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex's dividend payout ratio is presently 42.90%.
Teleflex Profile
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Read More

Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.